
Results
4
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
4 companies
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€95.35
7D
11.4%
1Y
24.9%
Oryzon Genomics
Market Cap: €222.5m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.87
7D
6.7%
1Y
3.1%
Ercros
Market Cap: €311.8m
Manufactures and sells chemical and pharmaceutical products in Spain and internationally.
ECR
€3.41
7D
0%
1Y
15.8%
Adolfo Domínguez
Market Cap: €47.5m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€5.15
7D
7.7%
1Y
11.5%